Facebook Linkedin Twitter
Inside Precision Medicine Takeda Signs Deal Worth $2.2 Billion with AC Immune for Alzheimer’s Vaccine

Takeda Pharmaceutical Company

Nerve cells affected by Alzheimer's disease, which may involve abnormal microglia cells.
News & Features

Takeda Signs Deal Worth $2.2 Billion with AC Immune for Alzheimer’s Vaccine

0
Multiple Sclerosis Nerve Disorder illustrated as a head with neurons fluorescing in the brain and damaged neurons to the right hand side
News & Features

SEQSTER Chosen to Drive Forward MS Care

0
Brain MRI Scan of Healthy Male ( Magnetic Resonance Imaging) High Resolution Medical Images
News & Features

AcuraStem and Takeda Ink $580M Deal That Includes ALS Targets

0
Rapamycin inhibiting protein kinase mTORC1
News & Features

Astellas and PeptiDream Ink $21M Plus Protein Degrader Deal 

0
Mother and preterm baby first touch
News & Features

Takeda Spins Off Rare Disease Therapeutics Company Oak Hill Bio

0
Capsule with DNA inside
News & Features

FDA, NIH and Private Partners Commit $76.5M to Launch the Bespoke Gene Therapy Consortium

0
3d illustration proteins with lymphocytes , t cells or cancer cells
News & Features

Takeda, Jounce Drug Candidate Mobilizes Immunity by Suppressing SUMOylation

0
Rady Children’s and Takeda Partner to Develop Treatments for Rare Genetic Diseases
Molecular Dx

Rady Children’s and Takeda Partner to Develop Treatments for Rare Genetic Diseases

Helen Albert
0
Takeda Invests in Patient-Centric Health Data Company Seqster
Informatics

Takeda Invests in Patient-Centric Health Data Company Seqster

Chris Anderson
0
Researchers Operating Chemistry Analyzer Machine
eBooks

Better Understanding of Post-Translation Modifications Driving Innovation

0
12Page 1 of 2

Related Content

Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.
Inside Precision Medicine